BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10332634)

  • 1. Assertive Community Treatment for patients with chronic and severe mental illness who abuse drugs.
    Wingerson D; Ries RK
    J Psychoactive Drugs; 1999; 31(1):13-8. PubMed ID: 10332634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition to low intensity case management in a VA Assertive Community Treatment model program.
    Rosenheck RA; Neale MS; Mohamed S
    Psychiatr Rehabil J; 2010; 33(4):288-96. PubMed ID: 20374987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovations in integrated dual diagnosis treatment in public managed care: the Choate dual diagnosis case rate program.
    Minkoff K; Regner J
    J Psychoactive Drugs; 1999; 31(1):3-12. PubMed ID: 10332633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assertive community treatment and associations with substance abuse problems.
    van Vugt MD; Kroon H; Delespaul PA; Mulder CL
    Community Ment Health J; 2014 May; 50(4):460-5. PubMed ID: 23771775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and outcomes of mental health services among patients in drug treatment.
    Hser YI; Grella C; Evans E; Huang YC
    J Addict Dis; 2006; 25(1):73-85. PubMed ID: 16597575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual diagnosis care for severe and persistent disorders. A comparison of three methods.
    Jerrell JM; Ridgely MS
    Behav Healthc Tomorrow; 1997 Jun; 6(3):26-33. PubMed ID: 10173086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rural collaborative model of treatment and recovery services for pregnant and parenting women with dual disorders.
    Ryland SA; Lucas L
    J Psychoactive Drugs; 1996; 28(4):389-95. PubMed ID: 9017559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severely and persistently mentally ill substance abusers: clinical and policy issues.
    Zweben JE
    J Psychoactive Drugs; 2000; 32(4):383-9. PubMed ID: 11210200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance misuse and mental health.
    Peters Z
    Ment Health Today; 2010 Mar; ():21-3. PubMed ID: 20429106
    [No Abstract]   [Full Text] [Related]  

  • 11. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veterans Affairs Intensive Case Management for older veterans.
    Mohamed S; Neale MS; Rosenheck R
    Am J Geriatr Psychiatry; 2009 Aug; 17(8):671-81. PubMed ID: 19625784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assertive community treatment: a resource for the Oklahoma medical community.
    Reantaso AA; Cates JB; Hopkins TS; Carnahan RM
    J Okla State Med Assoc; 2008 Apr; 101(4):79-82. PubMed ID: 18557582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a fidelity scale for function assertive community treatment (FACT)].
    van Vugt MD; van Veldhuizen JR; Bahler M; Delespaul P; Huffels N; Mulder CL; Nijboer G; Overdijk M; Kroon H
    Tijdschr Psychiatr; 2011; 53(2):119-24. PubMed ID: 21319068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
    Jerrell JM; Ridgely MS
    J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid-covered alcohol and drug treatment use among people with intellectual disabilities: evidence of disparities.
    Slayter E
    Intellect Dev Disabil; 2010 Oct; 48(5):361-74. PubMed ID: 20973699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting.
    Grella CE
    J Psychoactive Drugs; 1996; 28(4):319-43. PubMed ID: 9017555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Services for perinatal women with substance abuse and mental health disorders: the unmet need.
    Grella CE
    J Psychoactive Drugs; 1997; 29(1):67-78. PubMed ID: 9110267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.